Implementing a Collaborative Approach to Caring for Patients With Substance Use Disorders Requiring Outpatient Parenteral Antimicrobial Therapy After Discharge
Sara C. Keller(Johns Hopkins University), Megan Buresh(Johns Hopkins University), Armani M. Hawes(School of the Art Institute of Chicago), Jennifer Townsend(University of British Columbia), Lauren Groft Buzzalino(School of the Art Institute of Chicago), Jessa R. Brenon(School of the Art Institute of Chicago), William F Wright(School of the Art Institute of Chicago), Rawan Abdel Galil(Johns Hopkins University), Alex Hessel(School of the Art Institute of Chicago), Oluwaseun Falade‐Nwulia(Johns Hopkins University)
Cited by 1
Related Papers
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
|Annals of Internal Medicine|2017|694
Adverse interactions between antifungal azoles and vincristine: review and analysis of cases
|Mycoses|2011|159
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review
|UNC Libraries|2020|111
Understanding and addressing hepatitis C reinfection in the oral direct‐acting antiviral era
|Journal of Viral Hepatitis|2018|104